Accès ouvert
2025
article
OpenAlex
Marta Sánchez-Delgado, Maurice Frank, Tomáš Šišmiš, Mustafa Kahraman et autres
The characterisation of circulating nucleic acid biomarkers in liquid biopsy based diagnostics holds great potential to transform the landscape of early cancer detection and screening. These tests are increasingly incorporating information beyond the primary sequence, to include epigenetic, fragmentomic, and other chemical …
de
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Tobias Sikosek, Marco Heuvelman, Jagoda Mika, Mustafa Kahraman et autres
Abstract Background Alzheimer's disease (AD), the most common form of dementia, is typically diagnosed using the AT(N) framework, which assesses amyloid, tau, and neurodegeneration biomarkers. However, this framework has limitations, particularly in predicting cognitive decline among amyloid‐positive individuals. Method This study explores …
de, us, gb
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Tobias Sikosek, Marco Heuvelman, Mustafa Kahraman, Julia Jehn et autres
BACKGROUND: Alzheimer's disease (AD) is the most common form of dementia, and early diagnosis is crucial to enable effective interventions. Currently, Alzheimer's disease is diagnosed through cognitive assessments, brain imaging and fluid biomarkers focused on determining amyloid (A) and, tau (T) protein …
de, us, gb
(code pays fourni par la source)
Accès ouvert
2024
data-paper
OpenAlex
Julia Jehn, Franziska Christina Trudzinski, Rastislav Horos, Judith Schenz et autres
miR-Blood is a high-quality, small RNA expression atlas for the major components of human peripheral blood (plasma, erythrocytes, thrombocytes, monocytes, neutrophils, eosinophils, basophils, natural killer cells, CD4+ T cells, CD8+ T cells, and B cells). Based on the purified blood components from …
de
(code pays fourni par la source)
Accès ouvert
2023
conference-abstract
OpenAlex
Rastislav Horos, Alberto Daniel-Moreno, C Bieg-Salazar, Jasmin Skottke et autres
Abstract Background Small RNAs are an important class of biomarkers in liquid biopsy for cancer diagnostics. New discoveries in the field of “epitranscriptomics” have uncovered further functional layers of tumor biology that are ignored by standard gene expression measurement methods. Therefore, there …
de
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Tobias Sikosek, Rastislav Horos, Franziska Christina Trudzinski, Julia Jehn et autres
INTRODUCTION: Lung cancer remains the deadliest cancer in the world, and lung cancer survival is heavily dependent on tumor stage at the time of detection. Low-dose computed tomography screening can reduce mortality; however, annual screening is limited by low adherence in the …
de, us
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Anne S. Schmitz, Milena Korneck, Janani Raju, Andrés Lamsfus‐Calle et autres
Mutations in Colony-stimulating factor 1 receptor (CSF1R) lead to CSF1R-related leukoencephalopathy, also known as Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP), a rapidly progressing neurodegenerative disease with severe cognitive and motor impairment. In this study, a homozygous and a heterozygous …
de
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Guillermo Ureña-Bailén, Milena Block, Tommaso Grandi, Faidra Aivazidou et autres
Cellular therapies hold enormous potential for the cure of severe hematological and oncological disorders. The forefront of innovative gene therapy approaches including therapeutic gene editing and hematopoietic stem cell transplantation needs to be processed by good manufacturing practice to ensure safe application …
de, ae
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Yujuan Hou, Guillermo Ureña-Bailén, Tahereh Mohammadian Gol, Paul Gerhard Gratz et autres
X-linked severe combined immunodeficiency (X-SCID) is a primary immunodeficiency that is caused by mutations in the interleukin-2 receptor gamma (IL2RG) gene. Some patients present atypical X-SCID with mild clinical symptoms due to somatic revertant mosaicism. CRISPR/Cas9 and prime editing are two advanced …
de, us
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
Timothy Rajakumar, Rastislav Horos, Julia Jehn, Judith Schenz et autres
Immunotherapies have recently gained traction as highly effective therapies in a subset of late-stage cancers. Unfortunately, only a minority of patients experience the remarkable benefits of immunotherapies, whilst others fail to respond or even come to harm through immune-related adverse events. For …
de, gb, us
(code pays fourni par la source)
2021
book-chapter
OpenAlex
Guillermo Ureña-Bailén, Justin S. Antony, Yujuan Hou, Janani Raju et autres
The CRISPR/Cas breakthrough has greatly improved the biomedical research field and has accelerated the development of effective cellular therapies for the treatment of infectious and genetic diseases. Thanks to its simplicity, versatility, and easy access, this technology has widely spread around the …
2021
article
OpenAlex
Justin S. Antony, Alberto Daniel-Moreno, Andrés Lamsfus‐Calle, Janani Raju et autres
Metachromatic leukodystrophy (MLD) is a rare genetic disorder caused by mutations in the Arylsulfatase-A ( ARSA ) gene. The enzyme plays a key role in sulfatide metabolism in brain cells, and its deficiency leads to neurodegeneration. The clinical manifestations of MLD include …
de
(code pays fourni par la source)